XML 33 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
SEGMENT INFORMATION
9 Months Ended
Sep. 30, 2012
SEGMENT INFORMATION [Abstract]  
SEGMENT INFORMATION
6.     SEGMENT INFORMATION
 
The Company operates in a single operating segment by selling products to a global network of independent distributors that operates in a seamless manner from market to market, except for its operations in Mainland China.  In Mainland China, the Company utilizes an employed sales force, contractual sales promoters and direct sellers to sell its products through fixed retail locations.  Selling expenses are the Company's largest expense comprised of the commissions paid to its worldwide independent distributors as well as remuneration to its sales force in Mainland China. The Company manages its business primarily by managing its global sales force.  The Company does not use profitability reports on a regional or divisional basis for making business decisions.  However, the Company does report revenue in five geographic regions: North Asia, Greater China, South Asia/Pacific, Americas and Europe.
 
Revenue generated in each of these regions is set forth below (U.S. dollars in thousands):

 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
September 30,
 
 
September 30,
 
Revenue:
 
2012
 
 
2011
 
 
2012
 
 
2011
 
 
 
 
 
 
 
 
 
 
North Asia
 
$
184,743
 
 
$
184,322
 
 
$
544,638
 
 
$
546,853
 
Greater China
 
 
136,633
 
 
 
83,367
 
 
 
428,972
 
 
 
231,364
 
South Asia/Pacific
 
 
91,124
 
 
 
61,819
 
 
 
266,789
 
 
 
170,977
 
Americas
 
 
70,479
 
 
 
59,407
 
 
 
208,585
 
 
 
175,091
 
Europe
 
 
43,203
 
 
 
39,501
 
 
 
132,435
 
 
 
124,402
 
Totals
 
$
526,182
 
 
$
428,416
 
 
$
1,581,419
 
 
$
1,248,687
 


Revenue generated by each of the Company's three product lines is set forth below (U.S. dollars in thousands):

 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
September 30,
 
 
September 30,
 
Revenue:
 
2012
 
 
2011
 
 
2012
 
 
2011
 
 
 
 
 
 
 
 
 
 
Nu Skin
 
$
271,269
 
 
$
235,957
 
 
$
815,852
 
 
$
680,848
 
Pharmanex
 
 
253,121
 
 
 
190,073
 
 
 
759,718
 
 
 
560,374
 
Other
 
 
1,792
 
 
 
2,386
 
 
 
5,849
 
 
 
7,465
 
Totals
 
$
526,182
 
 
$
428,416
 
 
$
1,581,419
 
 
$
1,248,687
 

Additional information as to the Company's operations in its most significant geographic areas is set forth below (U.S. dollars in thousands):

 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
September 30,
 
 
September 30,
 
Revenue:
 
2012
 
 
2011
 
 
2012
 
 
2011
 
 
 
 
 
 
 
 
 
 
Japan
 
$
120,756
 
 
$
121,127
 
 
$
346,435
 
 
$
348,027
 
Hong Kong
 
 
31,905
 
 
 
13,172
 
 
 
150,694
 
 
 
37,792
 
South Korea
 
 
63,987
 
 
 
63,195
 
 
 
198,203
 
 
 
198,826
 
United States
 
 
56,382
 
 
 
48,850
 
 
 
167,783
 
 
 
145,701
 
Mainland China
 
 
68,242
 
 
 
42,105
 
 
 
176,379
 
 
 
111,271
 
Taiwan
 
 
36,486
 
 
 
28,090
 
 
 
101,899
 
 
 
82,301
 


Long-lived assets:
 
September 30, 2012
 
 
December 31, 2011
 
 
 
 
 
 
Japan
 
$
9,150
 
 
$
14,113
 
Hong Kong
 
 
644
 
 
 
1,030
 
South Korea
 
 
12,924
 
 
 
11,451
 
United States
 
 
137,747
 
 
 
98,205
 
Mainland China
 
 
21,254
 
 
 
15,135
 
Taiwan
 
 
1,812
 
 
 
1,556